Anatomy, Physiology and Pathogenesis of Bladder Overactivity

Multidisciplinary Management of Female Pelvic Floor Disorders

Volumn , Issue , 2006, Pages 51-63

  Chapple, Christopher R ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856797990     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07272-7.50010-6     Document Type: Chapter

References (38)

1. Dixon JS, Gosling JA The anatomy of the bladder, urethra and pelvic floor. Urodynamics: principles, practice and application 1994, Churchill Livingstone, New York. 2nd edn. A.R. Mundy, T.P. Stephenson, A.J. Wein (Eds.).
2. Dixon J, Gosling J Structure and innervation in the human. The physiology of the lower urinary tract 1987, Springer-Verlag, London. M. Torrens, J.F.B. Morrison (Eds.).
3. Chapple CR, Helm W, Blease S, et al. Asymptomatic bladder neck incontinence in nulliparous females. Br J Urol 1989, 64:357-359.
4. Mundy AR, Thomas PJ Clinical physiology of the bladder, urethra and pelvic floor. Urodynamics: principles, practice and application 1994, Churchill Livingstone, New York. 2nd edn. A.R. Mundy, T.P. Stephenson, A.J. Wein (Eds.).
5. Torrens M Human physiology. The physiology of the lower urinary tract 1987, Springer-Verlag, London. M. Torrens, J.F.B. Morrison (Eds.).
6. Morrison JFB Reflex control of the lower urinary tract. The physiology of the lower urinary tract 1987, Springer-Verlag, London. M. Torrens, J.F.B. Morrison (Eds.).
7. Morrison JFB Bladder control: role of higher levels of the central nervous system. The physiology of the lower urinary tract 1987, Springer-Verlag, London. M. Torrens, J.F.B. Morrison (Eds.).
8. Blok BF, Willemsen AT, Holstege G A PET study on brain control of micturition in humans. Brain 1997, 120:111-121.
9. Nour S, Svarer C, Kristensen JKI, Paulson OB, Law I Cerebral activation during micturition in normal men. Brain 2000, 123:781-789.
10. Blok BFM, Sturms LM, Holstege G A PET study on cortical and subcortical control of pelvic floor musculature in women. J Comp Neurol 1997, 389:535-544.
11. Craggs M, McFarlane J Neuromodulation of the lower urinary tract. Exp Physiol 1999, 84:149-160.
12. Blok BFM, Holstege G The central nervous system control of micturition in cats and humans. Behav Brain Res 1998, 92:119-125.
13. Abrams P Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society. Neurourol Urodynam 2002, 21:167-178.
14. Brading AF, Turner WH The unstable bladder: towards a common mechanism. Br J Urol 1994, 73:3-8.
15. Steers WD, Kolbeck S, Creedon D, Tuttle JB Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J Clin Invest 1991, 88:1709-1715.
16. Steers WD, Creedon DJ, Tuttle JB Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy. J Urol 1996, 155:379-385.
17. Fam BA, Sarkarati M, Yalla SV Spinal cord injury. Neurourology and urodynamics: principles and practice 1988, Collier Macmillan, London. S.V. Yalla, E.J. McGuire, A. Elbadawi, J.G. Blaivas (Eds.).
18. Fowler CJ Bladder afferents and their role in the overactive bladder. Urology 2002, 59(Suppl 5A):37-42.
19. Dasgupta P, Fowler CJ Chillies: from antiquity to urology. Br J Urol 1997, 80:845-852.
20. Smet PJ, Moore KH, Jonavicius J Distribution and colocalization of calcitonin gene-related peptide tachykinins and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder. Lab Invest 1997, 77:37-49.
21. Cruz F Vanilloid receptor and detrusor instability. Urology 2002, 59(Suppl 5A):51-60.
22. Elbadawi A, Yalla SV, Resnick NM Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urol 1993, 150:1668-1680.
23. Drake MJ, Mills IW, Gillespie JI Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet 2001, 358(9279):401-403.
24. Milsom I, Abrams P, Cardozo L, Roberts RG, Thuroff J, Wein AJ How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001, 87:760-766.
25. K-E Andersson, Appell R, Cardozo L, et al. Pharmacological treatment of urinary incontinence. Incontinence 2005, Health Publication Ltd, Plymouth. P. Abrams, L. Cardozo, S. Khoury, A. Wein (Eds.).
26. Bramble FJ The treatment of adult enuresis and urge incontinence by enterocystoplasty. Br J Urol 1992, 54:693-696.
27. Cartwright PC, Snow BW Bladder autoaugmentation: early clinical experience. J Urol 1989, 142:505-507.
28. Schmidt RA Advances in genitourinary neurostimulation. Neurosurgery 1986, 18:1041-1044.
29. Schulte-Baukloh H, Michael T, Schobert J, Stolze T, Knispel HH Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocoele: primary results. Urology 2002, 59(3):325-327.
30. Schurch B, Stöhrer M, Kramer G, Schmid DM, Gaul G, Hauri D Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000, 164:692-697.
31. Elliott SP, Meng MV, Anwar HP, Stoller ML Complete laparoscopic ileal cystoplasty. Urology 2002, 59(6):939-943.
32. Atala A New methods of bladder augmentation. BJU Int 2000, 85(Suppl):24-34.
33. McDougall EM, Clayman RV, Figenshau RS, Pearle MS Laparoscopic retropubic auto-augmentation of the bladder. J Urol 1995, 153:123-126.
34. Govier FE, Scott L, Nitti V, Kreder KJ, Rosenblatt P Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 2001, 165:1193-1198.
35. Kohli N, Rosenblatt PL Neuromodulation techniques for the treatment of the overactive bladder. Clin Obstet Gynecol 2002, 45(1):2180-2232.
36. Sautter T, Herzog A, Hauri D, Schurch B Transient paralysis of the bladder due to wound botulism. Eur Urol 2001, 39(5):610-612.
37. Reitz A, Stöhrer M, Kramer G, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004, 45(4):510-515.
38. Schurch B, de Seze M, Denys P, et al. Botox Detrusor Hyperreflexia Study Team. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005, 174(1):196-200.